Operating Profit Margin
since 2005
Calculation
Edwards Lifesciences Corp., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating income1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 32.30% | = | 100 | × | 1,690,300) | ÷ | 5,232,500) |
| Dec 31, 2020 | 20.46% | = | 100 | × | 897,600) | ÷ | 4,386,300) |
| Dec 31, 2019 | 26.38% | = | 100 | × | 1,146,800) | ÷ | 4,348,000) |
| Dec 31, 2018 | 20.10% | = | 100 | × | 748,200) | ÷ | 3,722,800) |
| Dec 31, 2017 | 31.71% | = | 100 | × | 1,089,400) | ÷ | 3,435,300) |
| Dec 31, 2016 | 25.35% | = | 100 | × | 751,200) | ÷ | 2,963,700) |
| Dec 31, 2015 | 0.00% | = | 100 | × | —) | ÷ | 2,493,700) |
| Dec 31, 2014 | 0.00% | = | 100 | × | —) | ÷ | 2,322,900) |
| Dec 31, 2013 | 0.00% | = | 100 | × | —) | ÷ | 2,045,500) |
| Dec 31, 2012 | 0.00% | = | 100 | × | —) | ÷ | 1,899,600) |
| Dec 31, 2011 | 0.00% | = | 100 | × | —) | ÷ | 1,678,600) |
| Dec 31, 2010 | 0.00% | = | 100 | × | —) | ÷ | 1,447,000) |
| Dec 31, 2009 | 0.00% | = | 100 | × | —) | ÷ | 1,321,400) |
| Dec 31, 2008 | 0.00% | = | 100 | × | —) | ÷ | 1,237,700) |
| Dec 31, 2007 | 0.00% | = | 100 | × | —) | ÷ | 1,091,100) |
| Dec 31, 2006 | 0.00% | = | 100 | × | —) | ÷ | 1,037,000) |
| Dec 31, 2005 | 0.00% | = | 100 | × | —) | ÷ | 997,900) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
A consistent and significant upward trajectory in net sales is evident from 2005 through 2021. Revenue grew from 997.9 million US dollars in 2005 to 5.23 billion US dollars by the end of 2021, representing a steady expansion of the company's market presence over the sixteen-year period.
- Revenue Growth Patterns
- Net sales exhibited uninterrupted annual growth. The acceleration became more pronounced after 2016, with sales increasing from approximately 2.96 billion US dollars in 2016 to over 5.23 billion US dollars in 2021.
- Operating Profit Margin Volatility
- Between 2016 and 2021, the operating profit margin experienced notable fluctuations, indicating inconsistent operational efficiency or varying expense levels relative to revenue. The margin fluctuated between a low of 20.10% in 2018 and a high of 32.30% in 2021.
- Profitability Cycles
- The operating margin demonstrated a cyclical pattern: it rose to 31.71% in 2017, dropped sharply to 20.10% in 2018, recovered to 26.38% in 2019, declined again to 20.46% in 2020, and finally peaked at 32.30% in 2021.
- Operating Income Correlation
- While net sales increased linearly, operating income showed higher variance. The most significant leap in operational profitability occurred in 2021, where operating income reached 1.69 billion US dollars, coinciding with the highest recorded operating profit margin in the period analyzed.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Edwards Lifesciences Corp., operating profit margin, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| Dec 31, 2021 | 32.30% | 19.56% | 31.89% | 14.89% | 8.40% |
| Dec 31, 2020 | 20.46% | 15.48% | 24.09% | 16.57% | 8.76% |
| Dec 31, 2019 | 26.38% | 14.21% | 30.69% | 20.51% | 8.19% |
| Dec 31, 2018 | 20.10% | 11.94% | 32.21% | 22.20% | 7.71% |
| Dec 31, 2017 | 31.71% | 6.30% | 33.71% | 17.94% | 7.60% |
| Dec 31, 2016 | 25.35% | 15.27% | 34.95% | 18.35% | 7.03% |
| Dec 31, 2015 | 0.00% | 14.05% | 31.04% | 18.59% | 7.05% |
| Dec 31, 2014 | 0.00% | 12.84% | 25.56% | 22.42% | 7.92% |
| Dec 31, 2013 | 0.00% | 12.03% | 37.64% | 26.53% | 7.90% |
| Dec 31, 2012 | 0.00% | 20.28% | 40.30% | 0.00% | 8.42% |
| Dec 31, 2011 | 0.00% | 14.81% | 39.54% | 0.00% | 8.36% |
| Dec 31, 2010 | 0.00% | 17.31% | 39.29% | 0.00% | 8.41% |
| Dec 31, 2009 | 0.00% | 20.27% | 35.87% | 0.00% | 7.35% |
| Dec 31, 2008 | 0.00% | 19.28% | 35.53% | 0.00% | 6.54% |
| Dec 31, 2007 | 0.00% | 17.67% | 34.41% | 0.00% | 10.57% |
| Dec 31, 2006 | 0.00% | 9.09% | 28.81% | 0.00% | 9.88% |
| Dec 31, 2005 | 0.00% | 19.53% | 30.25% | 0.00% | 11.98% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).